These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 11105743)

  • 1. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
    Teter CJ; Early JJ; Frachtling RJ
    J Clin Psychiatry; 2000 Nov; 61(11):872-3. PubMed ID: 11105743
    [No Abstract]   [Full Text] [Related]  

  • 2. Agranulocytosis and neutropenia with typical and atypical neuroleptics.
    Hong X; Wang X
    Am J Psychiatry; 2001 Oct; 158(10):1736-7. PubMed ID: 11579015
    [No Abstract]   [Full Text] [Related]  

  • 3. Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine.
    Weiss EL; Longhurst JG; Bowers MB; Mazure CM
    J Clin Psychopharmacol; 1999 Aug; 19(4):378-80. PubMed ID: 10440469
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
    Dernovsek MZ; Tavcar R
    Int Clin Psychopharmacol; 2000 Jul; 15(4):237-8. PubMed ID: 10954065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible neutropenia with olanzapine following clozapine-induced neutropenia.
    Thangadurai P; Jyothi KS; Gopalakrishnan R; Kuruvilla A; Jacob KS
    Am J Psychiatry; 2006 Jul; 163(7):1298. PubMed ID: 16816247
    [No Abstract]   [Full Text] [Related]  

  • 8. Switching clozapine responders to olanzapine.
    Littrell KH; Johnson CG; Hilligoss NM; Peabody CD; Littrell SH
    J Clin Psychiatry; 2000 Dec; 61(12):912-5. PubMed ID: 11206595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent priapism during treatment with clozapine and olanzapine.
    Compton MT; Saldivia A; Berry SA
    Am J Psychiatry; 2000 Apr; 157(4):659. PubMed ID: 10777416
    [No Abstract]   [Full Text] [Related]  

  • 10. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
    Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y
    J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences with clozapine and olanzapine.
    Chatterton R
    Aust N Z J Psychiatry; 1998 Jun; 32(3):463. PubMed ID: 9672741
    [No Abstract]   [Full Text] [Related]  

  • 12. Olanzapine-induced neutropenia after clozapine-induced neutropenia.
    Benedetti F; Cavallaro R; Smeraldi E
    Lancet; 1999 Aug; 354(9178):567. PubMed ID: 10470706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.
    Gianfrancesco FD; Grogg AL; Mahmoud RA; Wang RH; Nasrallah HA
    J Clin Psychiatry; 2002 Oct; 63(10):920-30. PubMed ID: 12416602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome L; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.
    Boot E; de Haan L
    Psychopharmacology (Berl); 2000 Jun; 150(3):347-8. PubMed ID: 10923763
    [No Abstract]   [Full Text] [Related]  

  • 16. Weight gain and antipsychotic medications.
    Aquila R; Emanuel M
    J Clin Psychiatry; 1999 May; 60(5):336-7. PubMed ID: 10362443
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypharmacy of 2 atypical antipsychotics.
    Rhoads E
    J Clin Psychiatry; 2000 Sep; 61(9):678-80. PubMed ID: 11030491
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine: safe during clozapine-induced agranulocytosis.
    Oyewumi LK; Al-Semaan Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):279-81. PubMed ID: 10770478
    [No Abstract]   [Full Text] [Related]  

  • 19. Weight gain and antipsychotic medication: differences between antipsychotic-free and treatment periods.
    Simpson MM; Goetz RR; Devlin MJ; Goetz SA; Walsh BT
    J Clin Psychiatry; 2001 Sep; 62(9):694-700. PubMed ID: 11681765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.
    Fanous A; Lindenmayer JP
    J Clin Psychopharmacol; 1999 Jun; 19(3):275-6. PubMed ID: 10350037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.